Chandigarh “Zombie” Incident: Is Fentanyl-Xylazine Entering India? | Sector 33B Mystery Explained скачать в хорошем качестве

Chandigarh “Zombie” Incident: Is Fentanyl-Xylazine Entering India? | Sector 33B Mystery Explained

A disturbing incident from Chandigarh Sector 33B has raised serious questions. A delivery worker was seen standing motionless for nearly two hours — unresponsive, silent, and completely disconnected. Eyewitnesses reported that he showed no reaction to his surroundings, prompting police intervention and medical evaluation. While the official cause is still under investigation, the visuals have sparked comparisons with cases reported in the United States involving a dangerous drug combination known as Fentanyl and Xylazine (commonly called “Tranq”). Fentanyl is a highly potent synthetic opioid, while Xylazine is a veterinary sedative. When combined, they can cause extreme sedation, immobilization, and a “frozen” state — often observed in several documented international cases. ⚠️ Important Disclaimer: There is NO official confirmation that this Chandigarh case is linked to Fentanyl or Xylazine. This video explores possibilities based on publicly available patterns and global reports. 🌍 Why This Matters • India, especially regions like Punjab, has previously faced drug-related challenges • Fentanyl is significantly more potent than traditional opioids • Global reports have linked precursor supply chains to international sources • If such substances enter existing networks, the impact could be severe ⸻ 📌 What We Know So Far • Incident Location: Chandigarh, Sector 33B • Individual: Reportedly a delivery worker • Condition: Unresponsive for ~2 hours • Action Taken: Police intervention, medical evaluation • Status: Official medical report awaited ⸻ 📢 Stay Informed This is not just a viral video — it could be an early warning sign, or it could be a medical emergency case. Only verified reports will confirm the truth. 👉 Share this video to spread awareness 👉 Comment if you’ve seen similar incidents 👉 Subscribe for fact-based, investigative updates